With the analysis among 1,932 patents, we discovered top 208 key players by total patent application. Schering Corp., Astex Therapeutics Ltd., Bristol Myers Squibb Co. are dominant in this area. They take 17.39% of the total patent filing.
New Jersey, United States
Patent: 145
Cambridgeshire, United Kingdom
Patent: 100
New York, United States
Patent: 91
New Jersey, United States
Patent: 82
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 74
F. Hoffmann-La Roche Ltd.
Maharashtra, India
Patent: 58
Basel-Stadt, Switzerland
Patent: 52
Bristol-Myers Squibb Pharma Co.
New York, United States
Patent: 50
With the analysis among 19 patents, we discovered top 8 start-ups by total patent application. GenFleet Therapeutics (Shanghai) Co., Ltd., NeoSome Life Sciences Llc, Histide AG are active in this area.
GenFleet Therapeutics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 7
NeoSome Life Sciences Llc
Massachusetts, United States
Patent: 4
Schwyz, Switzerland
Patent: 2
Cedilla Therapeutics, Inc.
Massachusetts, United States
Patent: 2
Carrick Therapeutics Ltd.
California, United States
Patent: 1
Sumitomo Dainippon Pharma Oncology, Inc.
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 1
With the analysis among related 222 patents applied in the last 5 years. We discover 91 most active companies in this area. The fast-growing Cothera Bioscience, Inc., Syros Pharmaceuticals, Inc., Dana-Farber Cancer Institute, Inc. take 18.92% of patent filing during this period.
Beijing Shi, China
Patent: 18
Syros Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 14
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 10
Lead Discovery Center GmbH
Nordrhein-Westfalen, Germany
Patent: 10
New York, United States
Patent: 10
Gyeonggi-do, South Korea
Patent: 9
eFFECTOR Therapeutics Operations, Inc.
California, United States
Patent: 7
St. Jude Children's Research Hospital, Inc.
Tennessee, United States
Patent: 6
GenFleet Therapeutics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 6
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Hebei Sheng, China
Patent: 6
With the analysis among related 222 patents in last 5 years, we discover 57 new entrants. Cothera Bioscience, Inc., Qurient Co., Ltd., eFFECTOR Therapeutics Operations, Inc. are the most active new entrants in this area.
Beijing Shi, China
Patent: 18
Gyeonggi-do, South Korea
Patent: 9
eFFECTOR Therapeutics Operations, Inc.
California, United States
Patent: 7
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Hebei Sheng, China
Patent: 6
Shanghai Junshi Biosciences Co., Ltd.
Shanghai Shi, China
Patent: 5
Risen Suzhou Pharmacy Tech Co Ltd
Jiangsu Sheng, China
Patent: 5
Institut Gustave Roussy EURL
Shengke Pharmaceutical (Jiangsu) Co., Ltd.
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 3
Kyoto Pharmaceutical Industries Ltd.
With the analysis among 276 patents, we discovered top 59 universities and scientific research institutions by total patent application. The University of North Carolina at Chapel Hill, Emory University, University of Saskatchewan are dominant in this area. They take 21.01% of the total patent filing.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 14
Georgia, United States
Patent: 12
University of Saskatchewan
Saskatchewan, Canada
Patent: 7
The Johns Hopkins University
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 5
Council of Scientific & Industrial Research
Thomas Jefferson University
Pennsylvania, United States
Patent: 4
Institut Gustave Roussy EURL
Université de Bretagne Occidentale